OpenVSafe by OpenVAERS
Search V-safe

EWN-15579-64003

1 vaccination 5 coded responses 10 check-ins 5 free-text entries 1 call case
Sex
Male
Age at first dose
61-65
ZIP prefix
209 / MD
Registered
2021-03-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Registered in v-safe
  2. 2021-03-24
    Dose 1 — Moderna
  3. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  4. 2021-03-30
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-03-31
    Health check-in — day 7, dose 1
    Feeling: Poor · Site: Pain · Muscle or body aches · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-07
    Survey response — day 14, dose 1
    MedDRA: Lymph node pain, Lymphadenopathy, Muscle spasms — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Lymphadenopathy related pain, quite severe at times when nodes spasm.Muscle spasm at right scapula triggered by the lymph pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-14
    Survey response — day 21, dose 1
    MedDRA: Lymphadenopathy — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Lymphadenopathy of injection arm, armpit, and proximate torso diagnosed 72 hours after the first Moderna dose. At 21 days post injection I still require treatment, currently with gabapentin, prednisone, Advil, and CBD/THC.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-21
    Health check-in — day 28, dose 1
    Feeling: Poor
    Adult check-in
  9. 2021-04-28
    Survey response — day 35, dose 1
    MedDRA: Pre-existing disease — Feeling: Fair
    Free text: Various normal symptoms and reactions to seasonal allergies.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-05-05
    Health check-in — day 42, dose 1
    Feeling: Fair
    Adult check-in
  11. 2021-06-25
    Survey response — 3 months, dose 1
    MedDRA: Anxiety, Back pain, Depression — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Musculoskeletal back pain not relieved by exercise.Anxiety Mild depression
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-09-22
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  13. 2022-03-14
    Call successful
    Participant prefers to complete VAERS report online
  14. 2022-03-24
    Survey response — 12 months, dose 1
    MedDRA: Lymphadenopathy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Recurrence of lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Moderna

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-07

Symptoms: Lymphadenopathy related pain, quite severe at times when nodes spasm.Muscle spasm at right scapula triggered by the lymph pain.

Release 7 — day 21, dose 1

2021-04-14

Symptoms: Lymphadenopathy of injection arm, armpit, and proximate torso diagnosed 72 hours after the first Moderna dose. At 21 days post injection I still require treatment, currently with gabapentin, prednisone, Advil, and CBD/THC.

Release 8 — day 35, dose 1

2021-04-28

Symptoms: Various normal symptoms and reactions to seasonal allergies.

Release 9 — 3 months, dose 1

2021-06-25

Symptoms: Musculoskeletal back pain not relieved by exercise.Anxiety Mild depression

Release 11 — 12 months, dose 1

2022-03-24

Symptoms: Recurrence of lymphadenopathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ ✓ ✓
SDBack pain ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SDLymph node pain ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDMuscle spasms ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release